Skip to main content
SpringerLink
Log in

Bladder Outlet Obstruction: Male Non-neurogenic

  • Chapter
  • First Online:
Interpretation of Basic and Advanced Urodynamics

  • 707 Accesses

Abstract

Benign prostatic hyperplasia (BPH) is common in aging males and is the most common cause of bladder outlet obstruction (BOO) in these patients. Over 80 % of men in their eighth decade have been diagnosed with BPH, and many will require one or more treatments for outflow obstruction throughout their lives. Additional causes of BOO include urethral strictures, lower urinary tract malignancy, and obstructing bladder stones. Diagnosing the cause of lower urinary tract symptoms (LUTS) in male patients may, at times, prove difficult. In patients for whom a diagnosis of BOO is suspected, urodynamic testing may aid in confirming this diagnosis, as well as determining the degree of obstruction. The American Urological Association recommends that urodynamic testing should be considered optional in the evaluation of patients presenting with LUTS suggestive of BOO.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fenter TC, Naslund MJ, Shah MB, Eaddy MT, Black L. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care. 2006;12(4 Suppl):S90–8.

    PubMed  Google Scholar 

  2. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.

    CAS  PubMed  Google Scholar 

  3. Rohr HP, Bartsch G. Human benign prostatic hyperplasia: a stromal disease? New perspectives by quantitative morphology. Urology. 1980;16(6):625–33.

    Article  CAS  PubMed  Google Scholar 

  4. Barry MJ, Fowler Jr FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57; discussion 64.

    CAS  PubMed  Google Scholar 

  5. Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology. 2001;58(6 Suppl 1):5–16; discussion.

    Article  CAS  PubMed  Google Scholar 

  6. Fenton AS, Morey AF, Aviles R, Garcia CR. Anterior urethral strictures: etiology and characteristics. Urology. 2005;65(6):1055–8.

    Article  PubMed  Google Scholar 

  7. Lumen N, Hoebeke P, Willemsen P, De Troyer B, Pieters R, Oosterlinck W. Etiology of urethral stricture disease in the 21st century. J Urol. 2009;182(3):983–7.

    Article  PubMed  Google Scholar 

  8. Mundy AR, Andrich DE. Urethral strictures. BJU Int. 2011;107(1):6–26.

    Article  PubMed  Google Scholar 

  9. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001;54(9):935–44.

    Article  CAS  PubMed  Google Scholar 

  10. Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int. 2015;115(1):24–31.

    Article  PubMed  Google Scholar 

  11. Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91(7):2562–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhang X, Zeng X, Liu Y, Dong L, Zhao X, Qu X. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int. 2014;93(2):214–9.

    Article  CAS  PubMed  Google Scholar 

  13. Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, et al. Risk behaviours and benign prostatic hyperplasia. BJU Int. 2004;93(9):1241–5.

    Article  CAS  PubMed  Google Scholar 

  14. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol. 2000;163(2):490–5.

    Article  CAS  PubMed  Google Scholar 

  15. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013;189(1 Suppl):S93–101.

    Article  CAS  PubMed  Google Scholar 

  16. McConnell JD, Roehrborn CG, Bautista OM, Andriole Jr GL, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–98.

    Article  CAS  PubMed  Google Scholar 

  17. Kaplan SA, Ikeguchi EF, Santarosa RP, D’Alisera PM, Hendricks J, Te AE, et al. Etiology of voiding dysfunction in men less than 50 years of age. Urology. 1996;47(6):836–9.

    Article  CAS  PubMed  Google Scholar 

  18. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803.

    Article  PubMed  Google Scholar 

  19. Blaivas JG. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation. Urol Clin North Am. 1990;17(3):543–52.

    CAS  PubMed  Google Scholar 

  20. Nitti VW. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7 Suppl 6:S14–21.

    PubMed  PubMed Central  Google Scholar 

  21. Abrams P, Griffiths D, Hoefner K. The urodynamic assessment of lower urinary tract symptoms. In: Chatelain C, Denis L, Foo K, editors. Benign prostatic hyperplasia. Plymouth: Health Publication; 2001. p. 227–81.

    Google Scholar 

  22. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84(1):14–5.

    Article  CAS  PubMed  Google Scholar 

  23. Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol. 1979;121(5):640–2.

    CAS  PubMed  Google Scholar 

  24. Oh MM, Choi H, Park MG, Kang SH, Cheon J, Bae JH, et al. Is there a correlation between the presence of idiopathic detrusor overactivity and the degree of bladder outlet obstruction? Urology. 2011;77(1):167–70.

    Article  PubMed  Google Scholar 

  25. Leng WW, McGuire EJ. Obstructive uropathy induced bladder dysfunction can be reversible: bladder compliance measures before and after treatment. J Urol. 2003;169(2):563–6.

    Article  PubMed  Google Scholar 

  26. Sotelo R, Clavijo R, Carmona O, Garcia A, Banda E, Miranda M, et al. Robotic simple prostatectomy. J Urol. 2008;179(2):513–5.

    Article  PubMed  Google Scholar 

  27. Perera M, Roberts MJ, Doi SA, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol. 2015;67(4):704–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Hofstra North Shore—LIJ, The Smith Institute for Urology, 450 Lakeville Rd, Suite M42, New Hyde Park, NY, 11042, USA

    Christopher Hartman M.D. & David Y. Chan M.D.

Authors
  1. Christopher Hartman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Y. Chan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher Hartman M.D. .

Editor information

Editors and Affiliations

  1. Hofstra Northwell School of Medicine, FPMRS, The Smith Institute for Urology, Lake Success, New York, USA

    Farzeen Firoozi

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hartman, C., Chan, D.Y. (2017). Bladder Outlet Obstruction: Male Non-neurogenic. In: Firoozi, F. (eds) Interpretation of Basic and Advanced Urodynamics. Springer, Cham. https://doi.org/10.1007/978-3-319-43247-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43247-2_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43245-8

  • Online ISBN: 978-3-319-43247-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation